Clinical considerations of lipid target and goal in dyslipidemia control
Saved in:
Main Authors: | Na-Qiong Wu, Jian-Jun Li |
---|---|
Format: | article |
Language: | EN |
Published: |
KeAi Communications Co., Ltd.
2016
|
Subjects: | |
Online Access: | https://doaj.org/article/02fa1ca9ad874cf6843bde9bc9135bc5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vaccine targeting ANGPTL3 ameliorates dyslipidemia and associated diseases in mouse models of obese dyslipidemia and familial hypercholesterolemia
by: Hirotaka Fukami, et al.
Published: (2021) -
Clinical utility and patient considerations in the use of ofatumumab in chronic lymphocytic leukemia
by: Frustaci AM, et al.
Published: (2015) -
Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy
by: Wang L, et al.
Published: (2012) -
Allium sativum, Hylocereus polyrhizus and its Combination Effectiveness on Lipid Profiles and Number of Foam Cells in Rats with Dyslipidemia
by: Wipi Sari Aisah, et al.
Published: (2019) -
New guidelines and evidence for prevention and treatment of dyslipidemia and atherosclerotic cardiovascular disease in China
by: Da-Yi Hu
Published: (2017)